LinkedIn Profile

Access Ezose Sciences historical Linkedin company profile data on number of followers, employee headcount and more

Rows

Open dataset
Ticker Symbol Entity Name As Of Date Company Name Followers Employees on Linkedin Link Industry Date Added Date Updated Description Website Specialities Logo HQ.Street HQ.City HQ.State HQ.Country HQ.Postal Headcount change in past 24 months Company Name Sector Industry
private:ezosesciences 564425 Mar 23rd, 2018 12:00AM Ezose Sciences 358 0.00 Open Biotechnology Mar 23rd, 2017 10:51AM Mar 23rd, 2017 10:51AM Ezose Sciences Inc., based in Pine Brook, NJ, provides High Throughput Glycan Analytical Services to support two key areas in life sciences R&D: 1) bioprocess development and 2) biomarker discovery. These services are based on our unique and proprietary GlycanMap® technology platform. Glycomics is the study of glycans, the sugar chains that during the post-translational process of glycosylation become attached to proteins. Glycomics has traditionally been hindered by the lack of practical high-throughput and quantitative glycan assay technologies. Our Glycan Analytical Services are designed to alleviate a common bottleneck in bioprocess development by facilitating the high-throughput analysis of drug glycoforms. Our Biomarker Discovery Services open up the largely unexplored human glycome, bringing a new dimension to biomarker discovery. We believe that exploration of the glycome provides an important compliment to existing efforts studying the genome and proteome. The GlycanMap® platform and new, lower cost GlycanMap® Xpress™ platform for bioprocessing both work by combining, in an automated 96-well format, high-throughput glycan enrichment with specialized MALDI-TOF mass spectrometry and custom bioinformatics to structurally identify and quantitate glycans present in biological samples. Established in 2009 as a US company, Ezose (pronounced ā-zōse) Sciences is an affiliate of the Diagnostics Division of Shionogi & Co., Ltd., Osaka, Japan. Ezose Sciences Pharmaceuticals & Biotechnology
private:ezosesciences 564425 Feb 17th, 2018 12:00AM Ezose Sciences 358 0.00 Open Biotechnology Feb 17th, 2018 02:25PM Feb 17th, 2018 02:25PM Ezose Sciences Inc., based in Pine Brook, NJ, provides High Throughput Glycan Analytical Services to support two key areas in life sciences R&D: 1) bioprocess development and 2) biomarker discovery. These services are based on our unique and proprietary GlycanMap® technology platform. Glycomics is the study of glycans, the sugar chains that during the post-translational process of glycosylation become attached to proteins. Glycomics has traditionally been hindered by the lack of practical high-throughput and quantitative glycan assay technologies. Our Glycan Analytical Services are designed to alleviate a common bottleneck in bioprocess development by facilitating the high-throughput analysis of drug glycoforms. Our Biomarker Discovery Services open up the largely unexplored human glycome, bringing a new dimension to biomarker discovery. We believe that exploration of the glycome provides an important compliment to existing efforts studying the genome and proteome. The GlycanMap® platform and new, lower cost GlycanMap® Xpress™ platform for bioprocessing both work by combining, in an automated 96-well format, high-throughput glycan enrichment with specialized MALDI-TOF mass spectrometry and custom bioinformatics to structurally identify and quantitate glycans present in biological samples. Established in 2009 as a US company, Ezose (pronounced ā-zōse) Sciences is an affiliate of the Diagnostics Division of Shionogi & Co., Ltd., Osaka, Japan. Ezose Sciences Pharmaceuticals & Biotechnology
private:ezosesciences 564425 Feb 16th, 2018 12:00AM Ezose Sciences 358 0.00 Open Biotechnology Feb 16th, 2017 08:15AM Feb 16th, 2017 08:15AM Ezose Sciences Inc., based in Pine Brook, NJ, provides High Throughput Glycan Analytical Services to support two key areas in life sciences R&D: 1) bioprocess development and 2) biomarker discovery. These services are based on our unique and proprietary GlycanMap® technology platform. Glycomics is the study of glycans, the sugar chains that during the post-translational process of glycosylation become attached to proteins. Glycomics has traditionally been hindered by the lack of practical high-throughput and quantitative glycan assay technologies. Our Glycan Analytical Services are designed to alleviate a common bottleneck in bioprocess development by facilitating the high-throughput analysis of drug glycoforms. Our Biomarker Discovery Services open up the largely unexplored human glycome, bringing a new dimension to biomarker discovery. We believe that exploration of the glycome provides an important compliment to existing efforts studying the genome and proteome. The GlycanMap® platform and new, lower cost GlycanMap® Xpress™ platform for bioprocessing both work by combining, in an automated 96-well format, high-throughput glycan enrichment with specialized MALDI-TOF mass spectrometry and custom bioinformatics to structurally identify and quantitate glycans present in biological samples. Established in 2009 as a US company, Ezose (pronounced ā-zōse) Sciences is an affiliate of the Diagnostics Division of Shionogi & Co., Ltd., Osaka, Japan. Ezose Sciences Pharmaceuticals & Biotechnology
private:ezosesciences 564425 Feb 15th, 2018 12:00AM Ezose Sciences 358 0.00 Open Biotechnology Feb 15th, 2017 10:07AM Feb 15th, 2017 10:07AM Ezose Sciences Inc., based in Pine Brook, NJ, provides High Throughput Glycan Analytical Services to support two key areas in life sciences R&D: 1) bioprocess development and 2) biomarker discovery. These services are based on our unique and proprietary GlycanMap® technology platform. Glycomics is the study of glycans, the sugar chains that during the post-translational process of glycosylation become attached to proteins. Glycomics has traditionally been hindered by the lack of practical high-throughput and quantitative glycan assay technologies. Our Glycan Analytical Services are designed to alleviate a common bottleneck in bioprocess development by facilitating the high-throughput analysis of drug glycoforms. Our Biomarker Discovery Services open up the largely unexplored human glycome, bringing a new dimension to biomarker discovery. We believe that exploration of the glycome provides an important compliment to existing efforts studying the genome and proteome. The GlycanMap® platform and new, lower cost GlycanMap® Xpress™ platform for bioprocessing both work by combining, in an automated 96-well format, high-throughput glycan enrichment with specialized MALDI-TOF mass spectrometry and custom bioinformatics to structurally identify and quantitate glycans present in biological samples. Established in 2009 as a US company, Ezose (pronounced ā-zōse) Sciences is an affiliate of the Diagnostics Division of Shionogi & Co., Ltd., Osaka, Japan. Ezose Sciences Pharmaceuticals & Biotechnology
private:ezosesciences 564425 Feb 14th, 2018 12:00AM Ezose Sciences 358 0.00 Open Biotechnology Feb 14th, 2017 01:50PM Feb 14th, 2017 01:50PM Ezose Sciences Inc., based in Pine Brook, NJ, provides High Throughput Glycan Analytical Services to support two key areas in life sciences R&D: 1) bioprocess development and 2) biomarker discovery. These services are based on our unique and proprietary GlycanMap® technology platform. Glycomics is the study of glycans, the sugar chains that during the post-translational process of glycosylation become attached to proteins. Glycomics has traditionally been hindered by the lack of practical high-throughput and quantitative glycan assay technologies. Our Glycan Analytical Services are designed to alleviate a common bottleneck in bioprocess development by facilitating the high-throughput analysis of drug glycoforms. Our Biomarker Discovery Services open up the largely unexplored human glycome, bringing a new dimension to biomarker discovery. We believe that exploration of the glycome provides an important compliment to existing efforts studying the genome and proteome. The GlycanMap® platform and new, lower cost GlycanMap® Xpress™ platform for bioprocessing both work by combining, in an automated 96-well format, high-throughput glycan enrichment with specialized MALDI-TOF mass spectrometry and custom bioinformatics to structurally identify and quantitate glycans present in biological samples. Established in 2009 as a US company, Ezose (pronounced ā-zōse) Sciences is an affiliate of the Diagnostics Division of Shionogi & Co., Ltd., Osaka, Japan. Ezose Sciences Pharmaceuticals & Biotechnology
private:ezosesciences 564425 Feb 13th, 2018 12:00AM Ezose Sciences 358 0.00 Open Biotechnology Feb 13th, 2017 04:11PM Feb 13th, 2017 04:11PM Ezose Sciences Inc., based in Pine Brook, NJ, provides High Throughput Glycan Analytical Services to support two key areas in life sciences R&D: 1) bioprocess development and 2) biomarker discovery. These services are based on our unique and proprietary GlycanMap® technology platform. Glycomics is the study of glycans, the sugar chains that during the post-translational process of glycosylation become attached to proteins. Glycomics has traditionally been hindered by the lack of practical high-throughput and quantitative glycan assay technologies. Our Glycan Analytical Services are designed to alleviate a common bottleneck in bioprocess development by facilitating the high-throughput analysis of drug glycoforms. Our Biomarker Discovery Services open up the largely unexplored human glycome, bringing a new dimension to biomarker discovery. We believe that exploration of the glycome provides an important compliment to existing efforts studying the genome and proteome. The GlycanMap® platform and new, lower cost GlycanMap® Xpress™ platform for bioprocessing both work by combining, in an automated 96-well format, high-throughput glycan enrichment with specialized MALDI-TOF mass spectrometry and custom bioinformatics to structurally identify and quantitate glycans present in biological samples. Established in 2009 as a US company, Ezose (pronounced ā-zōse) Sciences is an affiliate of the Diagnostics Division of Shionogi & Co., Ltd., Osaka, Japan. Ezose Sciences Pharmaceuticals & Biotechnology
private:ezosesciences 564425 Feb 12th, 2018 12:00AM Ezose Sciences 358 0.00 Open Biotechnology Feb 12th, 2017 04:15AM Feb 12th, 2017 04:15AM Ezose Sciences Inc., based in Pine Brook, NJ, provides High Throughput Glycan Analytical Services to support two key areas in life sciences R&D: 1) bioprocess development and 2) biomarker discovery. These services are based on our unique and proprietary GlycanMap® technology platform. Glycomics is the study of glycans, the sugar chains that during the post-translational process of glycosylation become attached to proteins. Glycomics has traditionally been hindered by the lack of practical high-throughput and quantitative glycan assay technologies. Our Glycan Analytical Services are designed to alleviate a common bottleneck in bioprocess development by facilitating the high-throughput analysis of drug glycoforms. Our Biomarker Discovery Services open up the largely unexplored human glycome, bringing a new dimension to biomarker discovery. We believe that exploration of the glycome provides an important compliment to existing efforts studying the genome and proteome. The GlycanMap® platform and new, lower cost GlycanMap® Xpress™ platform for bioprocessing both work by combining, in an automated 96-well format, high-throughput glycan enrichment with specialized MALDI-TOF mass spectrometry and custom bioinformatics to structurally identify and quantitate glycans present in biological samples. Established in 2009 as a US company, Ezose (pronounced ā-zōse) Sciences is an affiliate of the Diagnostics Division of Shionogi & Co., Ltd., Osaka, Japan. Ezose Sciences Pharmaceuticals & Biotechnology
private:ezosesciences 564425 Feb 11th, 2018 12:00AM Ezose Sciences 358 0.00 Open Biotechnology Feb 11th, 2017 05:35AM Feb 11th, 2017 05:35AM Ezose Sciences Inc., based in Pine Brook, NJ, provides High Throughput Glycan Analytical Services to support two key areas in life sciences R&D: 1) bioprocess development and 2) biomarker discovery. These services are based on our unique and proprietary GlycanMap® technology platform. Glycomics is the study of glycans, the sugar chains that during the post-translational process of glycosylation become attached to proteins. Glycomics has traditionally been hindered by the lack of practical high-throughput and quantitative glycan assay technologies. Our Glycan Analytical Services are designed to alleviate a common bottleneck in bioprocess development by facilitating the high-throughput analysis of drug glycoforms. Our Biomarker Discovery Services open up the largely unexplored human glycome, bringing a new dimension to biomarker discovery. We believe that exploration of the glycome provides an important compliment to existing efforts studying the genome and proteome. The GlycanMap® platform and new, lower cost GlycanMap® Xpress™ platform for bioprocessing both work by combining, in an automated 96-well format, high-throughput glycan enrichment with specialized MALDI-TOF mass spectrometry and custom bioinformatics to structurally identify and quantitate glycans present in biological samples. Established in 2009 as a US company, Ezose (pronounced ā-zōse) Sciences is an affiliate of the Diagnostics Division of Shionogi & Co., Ltd., Osaka, Japan. Ezose Sciences Pharmaceuticals & Biotechnology
private:ezosesciences 564425 Feb 10th, 2018 12:00AM Ezose Sciences 358 0.00 Open Biotechnology Feb 10th, 2017 06:43AM Feb 10th, 2017 06:43AM Ezose Sciences Inc., based in Pine Brook, NJ, provides High Throughput Glycan Analytical Services to support two key areas in life sciences R&D: 1) bioprocess development and 2) biomarker discovery. These services are based on our unique and proprietary GlycanMap® technology platform. Glycomics is the study of glycans, the sugar chains that during the post-translational process of glycosylation become attached to proteins. Glycomics has traditionally been hindered by the lack of practical high-throughput and quantitative glycan assay technologies. Our Glycan Analytical Services are designed to alleviate a common bottleneck in bioprocess development by facilitating the high-throughput analysis of drug glycoforms. Our Biomarker Discovery Services open up the largely unexplored human glycome, bringing a new dimension to biomarker discovery. We believe that exploration of the glycome provides an important compliment to existing efforts studying the genome and proteome. The GlycanMap® platform and new, lower cost GlycanMap® Xpress™ platform for bioprocessing both work by combining, in an automated 96-well format, high-throughput glycan enrichment with specialized MALDI-TOF mass spectrometry and custom bioinformatics to structurally identify and quantitate glycans present in biological samples. Established in 2009 as a US company, Ezose (pronounced ā-zōse) Sciences is an affiliate of the Diagnostics Division of Shionogi & Co., Ltd., Osaka, Japan. Ezose Sciences Pharmaceuticals & Biotechnology
private:ezosesciences 564425 Feb 9th, 2018 12:00AM Ezose Sciences 358 0.00 Open Biotechnology Feb 9th, 2017 08:57AM Feb 9th, 2017 08:57AM Ezose Sciences Inc., based in Pine Brook, NJ, provides High Throughput Glycan Analytical Services to support two key areas in life sciences R&D: 1) bioprocess development and 2) biomarker discovery. These services are based on our unique and proprietary GlycanMap® technology platform. Glycomics is the study of glycans, the sugar chains that during the post-translational process of glycosylation become attached to proteins. Glycomics has traditionally been hindered by the lack of practical high-throughput and quantitative glycan assay technologies. Our Glycan Analytical Services are designed to alleviate a common bottleneck in bioprocess development by facilitating the high-throughput analysis of drug glycoforms. Our Biomarker Discovery Services open up the largely unexplored human glycome, bringing a new dimension to biomarker discovery. We believe that exploration of the glycome provides an important compliment to existing efforts studying the genome and proteome. The GlycanMap® platform and new, lower cost GlycanMap® Xpress™ platform for bioprocessing both work by combining, in an automated 96-well format, high-throughput glycan enrichment with specialized MALDI-TOF mass spectrometry and custom bioinformatics to structurally identify and quantitate glycans present in biological samples. Established in 2009 as a US company, Ezose (pronounced ā-zōse) Sciences is an affiliate of the Diagnostics Division of Shionogi & Co., Ltd., Osaka, Japan. Ezose Sciences Pharmaceuticals & Biotechnology

Request a demo to view additional historical data, and much more.

Request Demo

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.

Add widgets to your dashboards

Access existing maps, charts, word clouds, and other visualizations to understand your data quickly. Or build custom widgets to view data just the way you want it.